baber/WOPTO huggingface dataset:
Patent NZ-571873-A (NZ)
Title: Wound dressing having laminate with pressure sensitive adhesive on one side and hydrophobic gel on other side
Inventor: COTTON STEPHEN
IPC: C09J7/29
Filed: 2007-04-03
Abstract: A releasably adhesive laminate (1) comprises a structural layer (2) carrying on at least part of one side thereof a hydrophobic gel (4) and on at least part of the other side thereof a pressure-sensitive adhesive (3). The structural layer (2) is preferably a film of synthetic plastics material, eg polyurethane. The pressure-sensitive adhesive (3) is preferably an acrylic adhesive, and the hydrophobic gel (4) is preferably a silicone gel. The laminate (1) may be used as a skin contact component of a wound dressing or in numerous other applications.
Patent NZ-572322-A (NZ)
Title: Improved dispensing apparatus
Inventor: CADDEN STEPHEN
IPC: B65D83/00
Filed: 2007-04-11
Abstract: An apparatus for storing and dispensing a product such as a two part adhesive includes a cartridge 220 with a sealing clip 226a containing the contents within the cartridge, a substantially rigid outer casing 202 that receives and snugly houses the cartridge, and a removable element 256 attached to the sealing clip. Pulling the removable element off the cartridge causes the sealing clip to be removed from the cartridge without rupturing the cartridge itself and allows the contents of the cartridge to be dispensed.
Patent NZ-572878-A (NZ)
Title: Counting devices for a pushup exercise
Inventor: MILLS ALDEN M
Filed: 2008-11-17
Abstract: A counting device (10) for counting repetitions and elapsed time of a push-up exercise is disclosed. The device includes a body (150), and a counter assembly (100) having a display and a plurality of actuation buttons. The counter assembly fits within a deformable foam ring that forms the top of the device. During exercise, a user depresses the foam ring downward with their chest a given distance so as to trigger at least one sensor in the counter assembly to register a repetition count on the display, along with an elapsed time of the exercise. The counter assembly can be fixed within the device, or a display may be removable so that the device and display unit are configured for wireless communication.
Patent NZ-573046-A (NZ)
Title: Snow traction unit with an endless track to replace a wheel of a vehicle
Inventor: MACKENZIE RODERICK
IPC: B62D11/20
Filed: 2007-06-08
Abstract: A snow traction unit (30) to replace a wheel of a vehicle is disclosed. The unit includes a) a frame supporting two carrier wheels (53, 54), b) the two carrier wheels (53, 54) which are spaced apart by a distance greater than their combined radii, c) an endless snow contacting track (35, 36, 37) mounted for rotation on the carrier wheels (53, 54), d) a drive engagement means for engaging the drive shaft of the vehicle and for driving at least one of the carrier wheels (53, 54), e) and a guide rail (40). The guide rail (40) is provided between the lower extremities of the carrier wheels and the snow contacting track moves over the guide rail (40). The guide rail (40) is constructed of low friction material and snow is allowed to enter between the surface of the track and the guide rail (40) to provide lubrication. The arrangement of the width of the track, the spacing between the carrier wheels (53, 54), and the track contacting surface (40) surface result in the vehicle having a force imprint less than 250Kg/square metre.
Patent NZ-579802-A (NZ)
Title: Compounds for improving the efficacy of other drugs
Inventor: DESAI MANOJ C
IPC: A61P31/12
Filed: 2008-02-22
Abstract: Disclosed is a pharmaceutical composition which comprises a compound of formula (a) which is ((thiazol-5-yl)methyl) (2R,5R)-5-(((S)-(3-((isopropylthiazol-4-yl)methyl)-3-methylureido)-2-(morpholinoethyl)ethyl)amido)-1,6-diphenylhexan-2-ylcarbamate, tenofovir disoproxil fumarate, emtricitabine and elvitegravir for the treatment of HIV infection.
Patent NZ-581363-A (NZ)
Title: New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
Inventor: SONESSON CLAS
IPC: A61K31/40
Filed: 2008-06-04
Abstract: Disclosed is a compound of formula (2): wherein: Ar is phenyl; R1 is selected from the group consisting of F and CI; R2 is selected from the group consisting of F and CI; and R3 is selected from the group consisting of H and Me, with the proviso that, when one of R1 and R2 is located in the para-position and the other of R1 and R2 is located in the meta-position, then R1 and R2 are not both F when R3 is H; any of its stereoisomers or any mixture of its stereo isomers, or an N-oxide thereof, or a pharmaceutically acceptable salt thereof. Also disclosed is the use of the said compound or the compound 3-(3,4-difluorophenyl)pyrrolidine; any of its stereo isomers or any mixture of its stereoisomers, or an N-oxide thereof, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament.
Patent NZ-582332-A (NZ)
Title: Formulations for the oral administration of amphotericin b and related methods
Inventor: WASAN KISHOR M
IPC: A61K31/7048
Filed: 2008-05-23
Abstract: Disclosed is an amphotericin B formulation, comprising, (a) amphotericin B; (b) one or more fatty acid glycerol esters; and (c) one or more polyethylene oxide-containing phospholipids or one or more polyethylene oxide-containing fatty acid esters. Also disclosed is the use of the formulation for treating fungal infections.
Patent NZ-588663-A (NZ)
Title: Anti-viral nutraceutical
Inventor: CUTHBERTSON ADRIAN
IPC: A61K35/56
Filed: 2009-04-21
Abstract: Patent No. 588663 Disclosed is the use of a preparation of whole abalone hemocyanin in the manufacture of a medicament for the prophylaxis or treatment of a herpesvirus in a mammal, the preparation excluding antigen for generation of an immune response to the herpesvirus.
Patent NZ-589373-A (NZ)
Title: Cannabinoids in combination with non -cannabinoid chemotherapeutic agents (e.g. serm or alkylating agents)
Inventor: VELASCO DIEZ GUILLERMO
IPC: A61K31/138
Filed: 2009-06-04
Abstract: 589373 Disclosed is the use of cannabinoid tetrahydrocannabinol (THC) in the form of a cannabis plant extract in combination with a non-cannabinoid chemotherapeutic agent selected from the group consisting of: an alkylating agent (such as alkyl sulfonates, busulfan, ethyleneimines, methylmelamines, hexamethymelamine, altretamine, thiotepa, nitrogen mustards, cyclophosphamide, mechlorethamine, mustine, uramustine, uracil mustard, melphalan, chlorambucil, ifosfamide, nitrosureas, carmustine, cisplatin, streptozocin, triazenes, decarbazine, imidazotetrazines and temozolomide) and a selective estrogen receptor modulator (such as afimoxifene (4-hydroxytamoxifen), arzoxifene, bazedoxifene, clomifene, lasofoxifene, ormeloxifene, ormeloxifene, raloxifene, tamoxifen and toremifene) in the manufacture of a medicament for the treatment of a brain tumour.
Patent NZ-595951-A (NZ)
Title: Antihypertensive agents
Inventor: HIRAYAMA MASAO
IPC: A61K31/353
Filed: 2011-10-25
Abstract: 595951 Discloses an antihypertensive agent comprising a Boysenberry seed water-soluble or a boysenberry seed water-containing organic solvent extract as an active ingredient, wherein the extract comprises a proanthocyanidin dimer or trimer extracted from boysenberry seed. Also discloses methods for producing the hypertensive agent and producing proanthocyanidin dimer or trimer.
Patent NZ-599224-A (NZ)
Title: Unbonded loosefill insulation
Inventor: GAVIN PATRICK M
IPC: E04B1/76
Filed: 2010-10-08
Abstract: An unbounded loosefill insulation material comprises a multiplicity of tufts and a plurality of voids between the tufts. The tufts have an outer surface that includes a plurality of irregularly-shaped projections. When installed in an insulation cavity, the average major tuft dimension of the tufts of the unbonded loosefill insulation material have a length that is in a range of from about 2.5 mm to about 7.6 mm.
Patent NZ-601527-A (NZ)
Title: Multi-purpose floatable container including linking assembly for connecting multiple containers
Inventor: WU PIN-CHIEN
IPC: B63B35/38
Filed: 2012-07-30
Abstract: 601527 A multi-purpose floating container is disclosed. The container comprises an abutting edge surrounding a top wall of a casing with the abutting edge including insert portions (131) formed at each corner of the casing. The insert portions (131) comprise a linking groove (134), and upper hole (135) through a top of the insert portion (131) and a lower hole (136) through a bottom of the insert portion (131). A rectangular cap (21) is mounted to the top of the casing and has buckling portions (22) on the corners with holes for securing the cap (21). At least one linking disc (30) is inserted into one of the linking grooves (131) having a connecting orifice (32) for aligning with the upper (135) and lower (136) holes. At least one buckling bolt (40) is mounted on the casing and inserted into the hole of one of the buckling portions (22) aligned with the connecting orifice (32), the upper hole (135), and the lower hole (136). The buckling bolt (40) allows for the cap (21) to be removed while holding the insert portion (131) to the linking disc (30).
Patent NZ-602990-A (NZ)
Title: Ganglioside micelles as a delivery system for hydrophobic drugs
Inventor: BELTRAMO DANTE
IPC: A61K31/7048
Filed: 2011-03-14
Abstract: The disclosure relates to water-soluble pharmaceutical compositions comprising at least one therapeutically active substance and at least one compound selected from among sialoglycosphingolipids, glycosphingolipids or a mixture of sialoglycosphingolipids and glycosphingolipids, in which at least one of the therapeutically active substances is a drug with hydrophobic characteristics. In particular, the disclosure relates to injectable sterile compositions formed by nanomicelles of glycosphingolipids or modified glycosphingolipids, which can be noncovalently coated with albumin and which allow the delivery and controlled release of highly hydrophobic molecules. Hydrophobic drugs of the present disclosure include: antitumor drugs, antimycotic drugs, paclitaxel, docetaxel, doxorubicin, amphotericin B, prostaglandins, isosorbide dinitrate, testosterone, nitroglycerin, estradiol, vitamin E, cortisone, dexamethasone and its esters and betamethasone valerate. Glycosphingolipids of the present disclosure include: gangliosides, monosialogangliosides, disialogangliosides, trisialogangliosides
Patent NZ-603558-A (NZ)
Title: Horseback riding spur mechanism
Inventor: COOK KARL
IPC: A43C17/02
Filed: 2010-10-26
Abstract: 603558 Disclosed is a spur attachable to a boot that provides improved stability of the spur on the footwear. The spur includes a body comprising a first arm, a second arm, a third arm, a fourth arm, and a neck with a separate head disposed on a distal end of each arm. The first arm, the second arm, the third arm, and the fourth arm are configured to be forward relative to a heel of the boot and the neck is configured to be rearward relative to the heel of the boot, and the third arm and fourth arm are configured to tighten a single strap attached to the head disposed on the distal end of each arm when the neck drops relative to the boot.
Patent NZ-604026-A (NZ)
Title: Injectable flowable composition comprising buprenorphine
Inventor: ZHOU MINGXING
IPC: A61K31/485
Filed: 2011-06-06
Abstract: The disclosure relates to a buprenorphine sustained release delivery system capable of delivering buprenorphine for duration of about 14 days to about 3 months. The buprenorphine sustained release delivery system includes a flowable composition and a solid implant for the sustained release of buprenorphine. The implant is produced from the flowable composition. The buprenorphine sustained release delivery system provides in situ 1-month and 3-month release profiles characterized by an exceptionally high bioavailability and minimal risk of permanent tissue damage and typically no risk of muscle necrosis. Particularly disclosed is an injectable flowable composition comprising: (a) about 5 wt% to about 25 wt% buprenorphine in the form of a free base or a pharmaceutically acceptable salt; (b) about 15 wt.% to about 70 wt.% of a poly(DL-lactide-coglycolide) copolymer; and (c) about 10 wt.% to about 90 wt.% of an organic liquid selected from the group consisting of N-methyl-2-pyrrolidone, 2-pyrrolidone, N,N-dimethylformamide, dimethyl sulfoxide, propylene carbonate, caprolactam, triacetin, polyethylene glycol, or a combination thereof; wherein the flowable composition forms a solid implant upon contact with a body fluid, an aqueous medium, or water.
Patent NZ-611920-A (NZ)
Title: Percutaneous absorption preparation containing rivastigmine
Inventor: YU HYUN-SUK
IPC: A61P25/28
Filed: 2011-12-22
Abstract: Disclosed is a percutaneous absorption preparation for treatment of dementia that comprises rivastigmine or its pharmaceutically acceptable salt as an active ingredient, a styrene-isoprene-styrene block copolymer, a tackifier resin, and a plasticizer, wherein the percutaneous absorption preparation is free from an intermediate layer between said backing layer and said drug-containing layer, or an adhesive layer in addition to said backing layer and said drug-containing layer, and wherein the drug-containing layer (b) does not comprise an organic acid or a salt thereof. This preparation contains a small amount of rivastigmine but allows a sufficient amount of the active ingredient penetrated into the skin to achieve an effective treatment of dementia.
Patent NZ-615557-A (NZ)
Title: Pyrrolo [2,3-d] pyrimidine derivatives as inhibitors of tropomyosin- related kinases
Inventor: ANDREWS MARK DAVID
IPC: A61K31/519
Filed: 2012-03-22
Abstract: Disclosed are pyrrolo[2,3-d]pyrimidine compounds of Formula (I) wherein the substituents are as described in the specification, which includes the compound N-(5-{ [2-amino-7-(2-hydroxy-1,1-dimethylethyl)-7H-pyrrolo[2,3-dlpyrimidin-5-yllcarbonyl} pyridin-3-yl)-2-[4-(trifluoromethyl)phenyllacetamide. Also disclosed are processes for the preparation of the compounds, compositions containing the compounds, and the uses of such compounds and salts in treating diseases or conditions associated with tropomyosin-related kinase (Trk), and activity. More specifically the invention relates to the compounds and their salts useful as inhibitors of Trk for the treatment of diseases or conditions such as pain and cancer.
Patent NZ-615682-A (NZ)
Title: Self cleaning refrigerated display case
Inventor: LAMONTAGNE RICK M
IPC: B32B5/20
Filed: 2013-09-19
Abstract: 615682 A self-cleaning merchandiser is disclosed. Tubing (264a-f) for the cleaning fluid is embedded in the foam used to insulate and bond the walls of the merchandiser together. Spray nozzles (240) within an air passageway are configured to spray fluid onto an evaporator. Spray nozzles (220) in the base (18) are used to direct a spray of water to a drain.
Patent NZ-616748-A (NZ)
Title: Microrna compounds and methods for modulating mir-21 activity
Inventor: BHAT BALKRISHEN
IPC: C12N15/113
Filed: 2012-04-25
Abstract: Disclosed is a compound comprising a modified oligonucleotide consisting of 16 to 22 linked nucleosides, wherein the nucleobase sequence of the modified oligonucleotide is complementary to miR-21 (SEQ ID NO: 1) and wherein the modified oligonucleotide comprises at least 16 contiguous nucleosides of the following nucleoside pattern I in the 5’ to 3’ orientation: (R)X-NB-NQ-NQ-NB-(NQ-NQ-NQ-NB)3-NQ-NZ wherein each R is, independently, a non-bicyclic nucleoside; X is from 1 to 4; each NB is, independently, a bicyclic nucleoside; each NQ is, independently, a non-bicyclic nucleoside; and NZ is a modified nucleoside, and wherein (i) each bicyclic nucleoside comprises a non-methylated nucleobase, or (ii) no more than two non-bicyclic nucleosides are 2’-O-methoxyethyl nucleosides and each other non-bicyclic nucleoside is a β-D-deoxyribonucleoside. Also disclosed is a compound comprising a modified oligonucleotide consisting of 16 to 19 linked nucleosides, wherein the nucleobase sequence of the modified oligonucleotide is complementary to miR-21 (SEQ ID NO: 1) and wherein the modified oligonucleotide comprises at least 16 contiguous nucleosides of the following nucleoside pattern III in the 5’ to 3’ orientation: (R)X-NB-NQ-NQ-NB-(NQ-NQ-NQ-NB)3-NY-NZ wherein each R is a non-bicyclic nucleoside; X is from 1 to 4; each NB is a bicyclic nucleoside; each NQ is a non-bicyclic nucleoside; NY is a modified nucleoside or an unmodified nucleoside; and NZ is a modified nucleoside, and wherein (i) each bicyclic nucleoside comprises a non-methylated nucleobase, or (ii) no more than two non-bicyclic nucleosides are 2’-O-methoxyethyl nucleosides and each other non-bicyclic nucleoside is a β-D-deoxyribonucleoside. Also disclosed is the use of the above-described compounds in the manufacture of a medicament for decreasing collagen expression in a cell, wherein the medicament is to be contacted to a cell.
Patent NZ-621221-A (NZ)
Title: Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
Inventor: BUGGY JOSEPH J
IPC: A61P35/00
Filed: 2011-09-13
Abstract: Provided are combinations and pharmaceutical compositions comprising bendamustine and a HDAC inhibitor. A preferred HDAC inhibitor is N-hydroxy-4-{ 2-[3-(N,N-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy} -benzamide. The combinations and pharmaceutical compositions are useful in the treatment of cancer.
Patent NZ-621880-A (NZ)
Title: An anti-vibration handle
Inventor: ANGELO LAMBRINOS NOTARAS
IPC: B25F5/00
Filed: 2014-02-27
Abstract: An anti-vibration blower handle for a hand-held blower having a motor or engine which induces vibration and a body to which the motor or engine is mounted. The anti-vibration handle includes a first elongate portion and a second outrigger portion. The first elongate portion has two ends, a generally longitudinal axis extending between the two ends and is shaped to be grasped by one hand of an operator between the ends. The second outrigger portion is located adjacent one of the ends of the first elongate portion and extends generally perpendicularly to the longitudinal axis of the first elongate portion. The second outrigger portion is firmly connected with the first elongate portion and terminates in a free end. The two ends of the first elongate portion and the free end of the second outrigger portion are each attached to the body of an appliance via a corresponding one of three coil springs. The outrigger portion restrains the first portion from rotating about its longitudinal axis due to flexing of the two springs connected to the two ends of the first elongate portion.
Patent NZ-628579-A (NZ)
Title: Filled and coated wafer confection product, method and mould for its production
Inventor: HARRIS ADAM
IPC: A23G3/54
Filed: 2013-05-16
Abstract: A candy bar, confection or baked product (2), which may be a wafer, comprising a plurality of product sections (4). Adjacent product sections mutually separated by a frangible portion (6). The frangible portions including at last one rib (8) extending across at least one of the frangible portions and interconnecting the adjacent product sections. The invention further provides a mould for making the products of the invention, and also a method for making them. The ribs add strength to the product so that the force needed to separate the sections is increased without effecting the clean break required when the product sections are separated.
Patent NZ-700756-A (NZ)
Title: Folding rule
Inventor: NEUGÄRTNER MARIO
IPC: G01B5/213
Filed: 2013-03-20
Abstract: The invention relates to a folding rule (1), comprising at least three links (1.1, 1.2, 1.3) that are pivotably fastened to each other. According to the invention, at least one of the links (1.1, 1.2, 1.3) has a scale (SD) for measuring the diameter of objects (O), which scale is designed in such a way that, when the object (O) is completely enclosed by three adjacent links (1.1, 1.2, 1.3), wherein insides (IS) of the three links (1.1, 1.2, 1.3) are each in contact with the object (O), a specified region (B) of one of the links (1.1, 1.2, 1.3) is in contact with the scale (SD) and a respective contact point on the scale (SD) indicates the diameter (D) of the object (O).
Patent NZ-707187-A (NZ)
Title: Barbecue grill with multifunction
Inventor: STEPHEN SPENCER
IPC: A47J37/07
Filed: 2014-02-28
Abstract: A pan holder 1 for a barbecue or portable cooker, including a framework so that the pan holder can be supported on the barbecue or portable cooker. The pan holder includes a ring for supporting a cooking utensil, and at least a panel adjacent the ring
Patent NZ-720949-A (NZ)
Title: Methods and compositions for treating aging-associated conditions
Inventor: WYSS-CORAY ANTON
IPC: A61P25/00
Filed: 2014-12-05
Abstract: Methods and compositions are provided for treating a subject for aging-associated conditions, e.g., cognitive impairment conditions. Aspects of the methods include administering a young plasma-comprising blood product to an individual in need thereof, e.g., an individual suffering from or at risk of developing the aging-associated condition, e.g., aging-associated cognitive impairment. Also provided are compositions and kits thereof that find use in practicing methods of the invention.
Patent NZ-728914-A (NZ)
Title: Aripiprazole prodrug compositions
Inventor: CRESSWELL PHILIP
IPC: A61K9/14
Filed: 2015-08-17
Abstract: Described is a composition comprising (a) a population of particles of an aripiprazole prodrug having a volume based particle size (Dv50) of less than 1000 nm and (b) at least one surface stabilizer comprising an adsorbed component which is adsorbed on the surface of the aripiprazole prodrug particles and a free component available for solubilisation of the aripiprazole prodrug. The surface stabilizer to prodrug ratio provides the optimal quantity of free surface stabilizer for the purposes of producing a lead-in formulation. Also described are methods of treatment using the aforementioned composition.
Patent NZ-739475-A (NZ)
Title: Mesh screen maximizing production in mytilidae cultivation
Inventor: SOBENES VENNEKOOL CATTERINA DEL PILAR
IPC: A01K61/00
Filed: 2018-01-29
Abstract: The present technology is a cultivation mesh screen (20) of minimum sieve that maximizes the aquaculture production and prevents tangling of the hangs, comprising: at least one cultivation hang (21) hanging from a mother longline (24) by means of holding means (22) and the mother longline (24) is joint to a controlled floatation means (4); attachment means (23), alternately jointing each cultivation hang (21) with an adjacent cultivation hang (21), thereby forming the cultivation mesh (20) with an area without sieve (25), wherein the cultivation mesh (20) is kept submerged under the water level (30) and the weight of the cultivation mesh (20) allows it to remain perpendicular with respect to the horizontal.
Patent NZ-749230-A (NZ)
Title: Two-component composition
Inventor: FREDRIKSON JOHN BJØRN
IPC: A61K9/48
Filed: 2017-06-28
Abstract: The present invention relates to a novel two-component composition comprising 100-600 mg acetylsalicylic acid (ASA) and an aqueous solution of an organic acid (e.g. acetic, lactic, citric, ascorbic, malonic, succinic, glutaric) with a pH 8-11.5. The pH after mixing the two components is 5-8. which Said composition is particularly useful in providing an aqueous solution of ASA for immediate peroral administration for treating myocardial infarction.
Patent NZ-752927-A (NZ)
Title: Measurement of susceptibility to diabetic foot ulcers
Inventor: BURNS MARTIN F
IPC: A61B5/053
Filed: 2018-02-02
Abstract: Diabetic foot ulcers is a complication of diabetes. 20-30% of the overall cost of treating diabetes is related to the treatment and care of diabetic foot ulcers after they occur. The current approach of prevention of this condition does not include detecting pre-ulcer condition. The present disclosure provides apparatuses and methods for measuring capacitance as an indication of susceptibility to the formation of a diabetic foot ulcer.